SCHEMBL28279915

SCHEMBL28279915

O=C(Nc1ccc(-c2cccc3c2C=CCC3)cc1)c1ccccc1I

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ CHRNB2 P17787 1/20 0.42
▸ CHRNB4 P30926 1/20 0.42
▸ CHRNA3 P32297 1/20 0.42
▸ CHRNA4 P43681 1/20 0.42
▸ AVPR2 P30518 2/20 0.39
▸ AVPR1A P37288 2/20 0.39
▸ OXTR P30559 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ PLAU P00749 1/20 0.38
▸ PLAT P00750 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ SMO Q99835 1/20 0.37
▸ F10 P00742 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28259961 0.89 MEN1 (0.47) MEN1KMT2ATDP1CHRNB2CHRNB4
SCHEMBL28426457 0.88 CHRNB2 (0.43) MEN1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL27972549 0.87 SMO (0.53) MEN1KMT2ATDP1SMOL3MBTL1
SCHEMBL27972568 0.87 MEN1 (0.53) MEN1KMT2ATDP1POLBALDH1A1
SCHEMBL28391966 0.85 SMN1; SMN2 (0.39) MEN1KMT2ATDP1CHRNB2CHRNB4
SCHEMBL28419971 0.84 MAPT (0.44) MEN1KMT2ATDP1POLBALDH1A1
SCHEMBL27972608 0.84 KCNK3 (0.50) KMT2APOLBGAAALDH1A1TP53
SCHEMBL28259950 0.84 NPC1 (0.51) MEN1KMT2ATDP1CHRNB2CHRNB4
SCHEMBL28259959 0.84 CHRNB2 (0.40) MEN1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL27972547 0.84 TSHR (0.40) MEN1KMT2ACHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108863959-B P2X4 receptor antagonists 日本化学药品株式会社 2021-11-30 — — CN claimed
CN-108863959-B P2X4 receptor antagonists 日本化学药品株式会社 2021-11-30 — — CN disclosed
CN-111333588-A P2X4 receptor antagonists 日本化学药品株式会社 2020-06-26 — — CN disclosed
CN-109414503-A The pharmaceuticals for the treatment of for multiple sclerosis 日本化学药品株式会社 2019-03-01 — — CN disclosed
Send feedback